Cencora, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
May 01, 2024 at 04:07 pm EDT
Share
Cencora, Inc. reported earnings results for the second quarter and six months ended March 31, 2024. For the second quarter, the company reported sales was USD 68,414.31 million compared to USD 63,457.21 million a year ago. Net income was USD 420.78 million compared to USD 435.4 million a year ago. Basic earnings per share from continuing operations was USD 2.11 compared to USD 2.15 a year ago. Diluted earnings per share from continuing operations was USD 2.09 compared to USD 2.13 a year ago.
For the six months, sales was USD 140,667.14 million compared to USD 126,304.04 million a year ago. Net income was USD 1,022.28 million compared to USD 915.15 million a year ago. Basic earnings per share from continuing operations was USD 5.12 compared to USD 4.5 a year ago. Diluted earnings per share from continuing operations was USD 5.07 compared to USD 4.46 a year ago.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
CENCORA, INC. 
